8-KLeadership ChangesExhibits & Filings

HCA Healthcare, Inc. 8-K Report, Executive Changes (Apr 3, 2017)

Filed April 3, 2017For Securities:HCA

Summary

This 8-K filing from HCA Healthcare, Inc. (HCA) on April 3, 2017, primarily details the adoption of the 2017 Senior Officer Performance Excellence Program (Senior Officer PEP). This program outlines the incentive compensation structure for the company's executive officers for the upcoming year, emphasizing a strong link between executive pay and both financial performance and quality of care. The Senior Officer PEP is weighted 80% towards EBITDA targets and 20% towards quality of care metrics. The EBITDA component is further divided, with specific weights for company-wide EBITDA and individual group EBITDA for certain presidents. The quality metrics include Hospital Acquired Infections, Core Measures, and Patient Experience. This structure aims to align executive incentives with key operational and strategic objectives critical for a healthcare provider.

Key Highlights

  • 1HCA Healthcare adopted the 2017 Senior Officer Performance Excellence Program (Senior Officer PEP) on March 29, 2017.
  • 2Executive compensation under the Senior Officer PEP is weighted 80% on EBITDA achievement and 20% on quality of care metrics.
  • 3EBITDA targets for certain Group Presidents are based 50% on Company EBITDA and 50% on their respective Group's EBITDA.
  • 4Quality of care metrics include Hospital Acquired Infections, Core Measures, and Patient Experience, each weighted equally within the quality portion.
  • 5Specific target award opportunities for named executive officers are outlined, ranging from 75% to 170% of base salary.
  • 6The program includes performance thresholds, target payouts, and maximum payout opportunities (up to 200% of target for EBITDA).
  • 7Awards under the Senior Officer PEP will be paid in cash, with provisions for adjustments and clawbacks under specific circumstances.

Frequently Asked Questions